Diabetes Drugs
- All
- News
- Videos
-
Hack It, Don't Work Hard: Does The Craze Around Ozempic Indicate India's Future Drug Dependency Over Holistic Wellness?
- Monday December 22, 2025
- Health | Written by Varsha Vats
GLP-1s were originally developed to manage diabetes by lowering blood sugar levels. However, the additional benefit of weight loss has gained more attention than their primary function of controlling
-
www.ndtv.com
-
What Happens When You Stop Taking Ozempic? 4 Possible Consequences
- Wednesday December 17, 2025
- Health | Written by Varsha Vats
Along with blood sugar control, Ozempic has shown to promote weight loss primarily due to its impact on appetite and gastric emptying.
-
www.ndtv.com
-
Popular Weight-Loss Drugs Like Wegovy Fail To Lower Obesity-Related Cancer Risks, Study Finds
- Tuesday December 16, 2025
- Health | Written by Debosmita Ghosh
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type 2 diabetes, overweight, or obesity. These studies involved a total of more than 94,000 participants.
-
www.ndtv.com
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
- Monday December 15, 2025
- Health | Written by Varsha Vats
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
www.ndtv.com
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
- Sunday December 14, 2025
- Health | Written by Tanushka Dutta
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
www.ndtv.com
-
Who Should Avoid Ozempic? Doctor Explains Why The Drug Is Not For Everyone
- Saturday December 13, 2025
- Health | Written by Debosmita Ghosh
Ozempic can be beneficial for a lot of people, however, some people should avoid it. Read on to know why the drug is not for everyone.
-
www.ndtv.com
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
- Friday December 12, 2025
- Health | Written by Rupashi Chhabra
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
www.ndtv.com
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
- Friday December 12, 2025
- Health | Written by Varsha Vats
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
www.ndtv.com
-
What Is Ozempic Neck? Causes, Signs And Can You Prevent It?
- Friday December 12, 2025
- Health | Written by Manya Singh
"Ozempic neck" is a popular term used to describe visible neck sagging, wrinkles or lax skin that some people report after rapid weight loss from Ozempic.
-
www.ndtv.com
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
www.ndtv.com
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
- Friday December 12, 2025
- Health | Written by Debosmita Ghosh
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
www.ndtv.com
-
Diabetes, Weight Loss Drug Ozempic Launched In India: See Dosage, Price And More
- Friday December 12, 2025
- Health | Indo-Asian News Service
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks.
-
www.ndtv.com
-
Ozempic, Type 2 Diabetes, Weight Loss Drug Launched In India. Check Price
- Friday December 12, 2025
- India News | Reuters
Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming diabetes and obesity market expected to power industry growth this decade.
-
www.ndtv.com
-
"Medication Alone Won't Reverse Obesity": WHO Issues Guidelines On GLP-1 Drugs
- Tuesday December 2, 2025
- Health | NDTV
The WHO guideline emphasises that medicines alone will not solve the problem.Addressing obesity requires a comprehensive approach.
-
www.ndtv.com
-
Hack It, Don't Work Hard: Does The Craze Around Ozempic Indicate India's Future Drug Dependency Over Holistic Wellness?
- Monday December 22, 2025
- Health | Written by Varsha Vats
GLP-1s were originally developed to manage diabetes by lowering blood sugar levels. However, the additional benefit of weight loss has gained more attention than their primary function of controlling
-
www.ndtv.com
-
What Happens When You Stop Taking Ozempic? 4 Possible Consequences
- Wednesday December 17, 2025
- Health | Written by Varsha Vats
Along with blood sugar control, Ozempic has shown to promote weight loss primarily due to its impact on appetite and gastric emptying.
-
www.ndtv.com
-
Popular Weight-Loss Drugs Like Wegovy Fail To Lower Obesity-Related Cancer Risks, Study Finds
- Tuesday December 16, 2025
- Health | Written by Debosmita Ghosh
Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type 2 diabetes, overweight, or obesity. These studies involved a total of more than 94,000 participants.
-
www.ndtv.com
-
Weight Loss Drugs In India: The Rise Of GLP-1s In 2025
- Monday December 15, 2025
- Health | Written by Varsha Vats
GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of appetite and insulin secretion. When administered, these medications stimulate insulin production.
-
www.ndtv.com
-
Ozempic Enters India: Diabetes Drug, Not A Miracle Fix, Novo Nordisk MD To NDTV
- Sunday December 14, 2025
- Health | Written by Tanushka Dutta
In an exclusive interaction with NDTV, Managing Director of Novo Nordisk India, Vikrant Shrotriya, said the launch of injectable semaglutide marks a significant moment for diabetes treatment.
-
www.ndtv.com
-
Who Should Avoid Ozempic? Doctor Explains Why The Drug Is Not For Everyone
- Saturday December 13, 2025
- Health | Written by Debosmita Ghosh
Ozempic can be beneficial for a lot of people, however, some people should avoid it. Read on to know why the drug is not for everyone.
-
www.ndtv.com
-
Ozempic Too Costly? 7 Cheaper And Clinically Approved Alternatives Available In India
- Friday December 12, 2025
- Health | Written by Rupashi Chhabra
Ozempic has hit the Indian market and will be available at Rs 2,200 per week. But did you know that there are alternatives which can also aid in weight loss?
-
www.ndtv.com
-
Can Non-Diabetics Take Ozempic For Weight Loss? Doctor Answers
- Friday December 12, 2025
- Health | Written by Varsha Vats
Ozempic is the brand name for a medication called semaglutide, which is primarily used to manage type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists
-
www.ndtv.com
-
What Is Ozempic Neck? Causes, Signs And Can You Prevent It?
- Friday December 12, 2025
- Health | Written by Manya Singh
"Ozempic neck" is a popular term used to describe visible neck sagging, wrinkles or lax skin that some people report after rapid weight loss from Ozempic.
-
www.ndtv.com
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
www.ndtv.com
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
- Friday December 12, 2025
- Health | Written by Debosmita Ghosh
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
www.ndtv.com
-
Diabetes, Weight Loss Drug Ozempic Launched In India: See Dosage, Price And More
- Friday December 12, 2025
- Health | Indo-Asian News Service
Novo Nordisk on Friday launched its blockbuster weight-loss drug Ozempic in India, beginning at Rs 8,800 a month or four weeks.
-
www.ndtv.com
-
Ozempic, Type 2 Diabetes, Weight Loss Drug Launched In India. Check Price
- Friday December 12, 2025
- India News | Reuters
Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming diabetes and obesity market expected to power industry growth this decade.
-
www.ndtv.com
-
"Medication Alone Won't Reverse Obesity": WHO Issues Guidelines On GLP-1 Drugs
- Tuesday December 2, 2025
- Health | NDTV
The WHO guideline emphasises that medicines alone will not solve the problem.Addressing obesity requires a comprehensive approach.
-
www.ndtv.com